DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20211163

Ovarian dysgerminoma: a case report

Shamrao Ramji Wakode, Varsha Narayana Bhat

Abstract


An ovarian dysgerminoma is a rare, malignant tumour occurring in young women, accounting for 1% to 2% of all primary ovarian neoplasms. A 22 years old female presented with 6 months of amenorrhea and lump in the abdomen. Her physical examination was remarkable with 36 weeks sized huge abdominal mass. Subsequent computed tomography revealed 22×23×32.4 cm mixed density lesion in pelvi-abdominal region and multiple paraaortic and mesenteric lymph node with gross pleural effusion. On further evaluation raised beta-hcG and LDH were noted and hence dysgerminoma was suspected. Total abdominal hysterectomy with right salpingo-ophorectomy with resection of tumour mass with partial omentectomy and lymphadenectomy was performed. Histopathology reports were suggestive of dysgerminoma.

 


Keywords


Dysgerminoma, Malignant ovarian tumor, Surgical intervention

Full Text:

PDF

References


Smith HO, Berwick M, Verschraegen CF, Wiggins C, Lansing L, Muller CY, et al. Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol. 2006;107(5):1075-85.

Cancer survival by stage at diagnosis for England (experimental statistics): Adults diagnosed 2012, 2013 and 2014 and followed up to 2015; Office for National Statistics (ONS). 2015.

Yoon S, Park HG, Kuk JY, Oak SA, Park JH. A case of ovarian dysgerminoma with dysgenesis in 29-year-old woman with 46,XX karyotype. Korean J Obstet Gynecol. 2012;55(10):772-6.

Tangjitgamsol S, Hanprasertpong J, Manusirvithaya S, Wootipoom V, Thavaramara T, Buhachat R. Malignant ovarian germ cell tumors: clinic-pathological presentation and survival outcomes. ActaObstetGynecol Scand. 2010;89(2):182-9.

Vicus D, Beiner M, Klachook S, Le L, Laframboise S, Mackay H. Purge dysgerminoma of the ovary 35 years on: A single institutional experiences. GynecolOncol. 2010:117(1):23-6.

Biswajit D, Patil CN, Sagar TG. Clinical presentation and outcome of pediatric ovarian germ cell tumor: A study of 40 petients. J Pediatric Hematol Oncol.2010;32(2):e54-e56.

Kumar S, Shah JP, Bryant CS, Imudia AN, Cote ML, AliFehmi R, et al. “The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary,” GynecolOncol. 2008;110(2):125-32.

Lee IH, Choi CH, Hong DG, Song JY, Kim YJ, Kim KT.et al. Clinicopathologic characteristics of granulosa cell tumors of the ovary: a multicenter retrospective study. J GynecolOncol. 2011;22:188-95.

Lu KH, Gershenson DM: Update on the management of ovarian germ cell tumors. J Reprod Med. 2005;50:417-425.

Husaini HAL, Soudy H, Darwish AED. Pure dysgerminona of the ovary: a single institutional experience of 65 patients. Med Oncol. 2012;29:2944-8.

Guerriero S, Testa AC, Timmerman D. Imaging of gynecological disease (6): clinical and ultrasound characteristics of ovarian dysgerminoma. Ultrasound Obstet Gynecol. 2011;37:596-602.

Baker PM, Oliva E. Germ cell tumors of the ovary. In, Nucci MR, Oliva E (eds): Gynecologic Pathology. London, Elsevier Churchill Livingstone. 2009;501-7.

Vicus D, Beiner M, Klachook S, Le L, Laframboise S, Mackay H. Purge dysgerminoma of the ovary 35 years on: A single institutional experiences. GynecolOncol. 2010;117(1):23-6.

Pautier P, Gutierrez-Bonnaire M, Rey A, Sillet-Bach I, Chevrean C, Kerbrat P, et al. Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors. Int J Gynecol Cancer. 2008;18:446-52.

Talukadar S, Kumar S, Bhatla N, Mathur S, Thulkar S, Kumar L. Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary. Gynecol Oncol. 2014;132:28.